Antioxidant effects of maslinic acid in livers, hearts and kidneys of streptozotocin-induced diabetic rats: Effects on kidney function

Renal Failure

Volumn 36, Issue 3, 2014, Pages 419-431

  Mkhwanazi, Blessing N ^a   Serumula, Metse R ^a   Myburg, Rene B ^a   Van Heerden, Fanie R ^a   Musabayane, Cephas T ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

Antioxidant; Diabetes; Glutathione peroxidase; Kidney; Malondialdehyde and superoxide dismutase; Maslinic acid

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; GLUTATHIONE PEROXIDASE; LIPID; LITHIUM; MALONALDEHYDE; MASLINIC ACID; METFORMIN; SODIUM CHLORIDE; SODIUM ION; STREPTOZOCIN; SUPEROXIDE DISMUTASE; ANTIOXIDANT; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORTER; GLYCOGEN; INSULIN; SODIUM; TRITERPENE;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DRUG EFFICACY; ENZYME ACTIVITY; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEART; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; KIDNEY FUNCTION; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; LIPID PEROXIDATION; LIVER; MALE; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PATHOGENESIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REDUCTION; SODIUM ABSORPTION; SODIUM URINE LEVEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TREATMENT DURATION; ANIMAL; BLOOD; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; DRUG EFFECTS; ELECTROLYTE BALANCE; HEART MUSCLE; METABOLISM; PATHOPHYSIOLOGY; SECRETION (PROCESS); WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DRINKING; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GLYCOGEN; HEART; INSULIN; KIDNEY TUBULES, PROXIMAL; LIPID PEROXIDATION; LIVER; MALONDIALDEHYDE; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, WISTAR; SODIUM; TRITERPENES; WATER-ELECTROLYTE BALANCE;

EID: 84896452432     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2013.867799     Document Type: Article

References (50)

1. Dzubak P, Hajduch M, Vydra D, et al. Pharmacological activities of natural triterpenoids and their therapeutic implications. Nat Prod Rep. 2006;23:394-411.
2. Reyes-Zurita FJ, Rufino-Palomares EE, Lupiáñez JA, Cascante M. Maslinic acid, a natural triterpene from Olea europaea L., induces apoptosis in HT29 human colon-cancer cells via the mitochondrial apoptotic pathway. Cancer Lett. 2009;273:44-54.
3. Di Carli MF, Janisse J, Grunberger G, Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol. 2003;41:1387-1393.
4. Parra A, Rivas F, Lopez PE, et al. Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides. Bioorg Med Chem. 2009; 17:1139-1145.
5. Allouche Y, Beltrán G, Gaforio JJ, Uceda M, Mesa MD. Antioxidant and antiatherogenic activities of pentacyclic triterpenic diols and acids. Food Chem Toxicol. 2010;48:2885-2890.
6. Liu J, Sun H, Duan W, Mu D, Zhang L. Maslinic acid reduces blood glucose in KK-Ay mice. Biol Pharm Bull. 2007;30:2075-2078.
7. Tang XZ, Guan T, Qian YS, et al. Effects of maslinic acid as a novel glycogen phosphorylase inhibitor on blood glucose and hepatic glycogen in mice. Chin J Nat Med. 2008;6:53-56.
8. Mkhwanazi B, Masola B, van Heerden F, Musabayane C. Effects of Syzygium aromaticum-derived maslinic acid on blood glucose of streptozotocin induced-diabetic rats. Endocr Abs. 2012;28:P214.
9. Kocak G, Aktan F, Canbolat O, et al. Alpha-lipoic acid treatment ameliorates metabolic parameters, blood pressure, vascular reactivity and morphology of vessels already damaged by streptozotocindiabetes. Diabetes Nutr Metab. 2000;13:308-318.
10. Pari L, Latha M. Protective role of Scoparia dulcis plant extract on brain antioxidant status and lipidperoxidation in STZ diabetic male Wistar rats. BMC Complement Altern Med. 2004;4:16-24.
11. Azuma K, Minami Y, Ippoushi K, Terao J. Lowering effects of onion intake on oxidative stress biomarkers in streptozotocininduced diabetic rats. J Clin Biochem Nutr. 2007;40:131-140.
12. Musabayane CT, Ndhlovu CE, Balment RJ. Renal fluid and electrolyte handling in streptozotocin induced diabetic rats. Ren Fail. 1995;17:107-116.
13. Li Y, Higashiura K, Ura N, et al. Effects of the Chinese medicine, TSJN on insulin resistance and hypertension in fructose-fed rats. Hypertens Res. 2000;23:101-107.
14. Krishnan R, Izatt S, Bargman JM, Oreopoulos D. Prevalence and determinants of erectile dysfunction in patients on peritoneal dialysis. Int Urol Nephrol. 2003;35:553-556.
15. Fujita H, Fujishima H, Chida S, et al. Reduction of renal superoxide dismutase in progressive diabetic nephropathy. J Am Soc Nephrol. 2009;20:1303-1313.
16. Kramer CK, Leitao CB, Pinto LC, et al. Risk factors for micro and macrovascular disease in black and white patients with type 2 diabetes mellitus. Rev Assoc Med Bras. 2009;55:308-314.
17. Weinberg JM. The cell biology of ischemic renal injury. Kidney Int. 1991;39:476-500.
18. Dominguez JH, Camp K, Maianu L, Feister H, Garvey WT. Molecular adaptations of GLUT1 and GLUT2 in renal proximal tubules of diabetic rats. Am J Physiol. 1994;266:F283-F290.
19. Mapanga RF, Tufts MA, Shode FO, Musabayane CT. Renal effects of plant-derived oleanolic acid in streptozotocin-induced diabetic rats. Ren Fail. 2009;31:481-491.
20. Somova LO, Nada A, Rammana P, Shode FO. Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine. 2003;10: 115-121.
21. Thomsen K, Shirley DG. The validity of lithium clearance as an index of sodium and water delivery from the proximal tubules. Nephron. 1997;77:125-138.
22. Shalmi M, Thomsen K. Alterations of lithium clearance in rats by different modes of lithium administration. Ren Physiol Biochem. 1989;12:273-280.
23. Madlala HP, Masola B, Singh M, Musabayane CT. The effects of Syzygium aromaticum-derived oleanolic acid on kidney function of male Sprague-Dawley rats and on kidney and liver cell lines. Ren Fail. 2012;34:767-776.
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem. 1951; 193:265-275.
25. Ngubane PS, Masola B, Musabayane CT. The effects of Syzygium aromaticum-derived oleanolic acid on glycogenic enzymes in streptozotocin- induced diabetic rats. Ren Fail. 2011;33:434-439.
26. Musabayane CT, Tufts MA, Mapanga RF. Synergistic antihyperglycemic effects between plant-derived oleanolic acid and insulin in streptozotocin- induced diabetic rats. Ren Fail. 2010;32:832-839.
27. Musabayane CT, Mahlalela N, Shode FO, Ojewole JAO. Effects of Syzygium cordatum (Hochst.)[Myrtaceae] leaf extract on plasma glucose and hepatic glycogen in streptozotocin induced diabetic rats. J Ethnopharmacol. 2005;97:485-490.
28. Garcia-Granados A, Martinez A, Moliz JN, Parra A, Rivas F. 2-a, 3-b-Dihydroxyolean-12-en-28-oic acid (maslinic acid). Molecules. 1998;3(3):88.
29. Júlio CAT, Gentil JV, Cleuza CS. A new tormentic acid derivative from Luehea divaricata Mart. (Tiliaceae). J Braz Chem Soc. 2003; 14:475-478.
30. Lenzen S. The mechanisms of alloxan- and streptozotocin-induced diabetes. Diabetologia. 2008;51:216-226.
31. Kuramochi G, Homma S. Effects of furosemide on renal oxygen consumption after ischemia in normal and streptozotocin diabetic rats. Nephron. 1993;64:436-442.
32. Bhor VM, Raghuram N, Sivakami S. Oxidative damage and altered antioxidant enzyme activities in the small intestine of streptozotocin- induced diabetic rats. Int J Biochem Cell Biol. 2004;36:89-97.
33. Miyake Y, Yamamoto K, Tsujihara N, Osawa T. Protective effects of lemon flavonoids on oxidative stress in diabetic rats. Lipids. 1998;33:689-695.
34. Arivazhagan P, Thilakovathy T, Panneerselvam C. Antioxidant lipoate and tissue antioxidants in aged rats. J Nutr Biochem. 2000; 11:122-127.
35. McCord JM. The evolution of free radicals and oxidative stress. Am J Med. 2000;108:652-658.
36. Montilla MP, Agil A, Navarro MC, et al. Antioxidant activity of maslinic acid, a triterpene derivative obtained from Olea europaea. Planta Medica. 2003;69:472-474.
37. Narasimhanaidu K, Ponnaian SMP. Antihyperglycaemic and antioxidant effect of rutin, a polyphenolic flavonoid, in streptozotocininduced diabetic Wistar rats. Basic Clin Pharm Toxicol. 2006;98: 97-103.
38. Xu Q, Chen G, Fan J, et al. Chemical constituents of roots of Boehmeria nivea. Zhongguo Zhong Yao Za Zhi. 2009;34: 2610-2612.
39. Yamabe N, Yokozawa T, Oya T, Kim M. Therapeutic potential of (-)-epigallocatechin 3-O-gallate on renal damage in diabetic nephropathy model rats. J Pharmacol Exp Ther. 2006;319: 228-236.
40. Agardh CD, Eckert B, Agardh E. Irreversible progression of severe retinopathy in young type I insulin-dependent diabetes mellitus patients after improved metabolic control. J Diabetes Complications. 1992;6:96-100.
41. Soulis-Liparota T, Cooper ME, Dunlop M, Jerums G. The relative roles of advanced glycation, oxidation and aldose reductase inhibition in the development of experimental diabetic nephropathy in the Sprague-Dawley rat. Diabetologia. 1995;38:387-394.
42. Obrosova IG, Fathallah L, Liu E, Nourooz-Zadeh J. Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid. Free Radic Biol Med. 2003;34:186-195.
43. Boer WH, Fransen R, Shirley DG, Walter SJ, Boer P, Koomans HA. Evaluation of the lithium clearance method: direct analysis of tubular lithium handling by micropuncture. Kidney Int. 1995;47: 1023-1030.
44. Shirley DG, Walter SJ. Renal tubular lithium reabsorption in potassium-depleted rats. J Physiol. 1997;501:663-670.
45. Szkudelski T. The mechanism of alloxan and streptozotocin action in b-cells of the rat pancreas. Physiol Res. 2001;50:537-546.
46. Marks J, Carvou NJ, Debnam ES, Srai SK, Unwin RJ. Diabetes increases facilitative glucose uptake and GLUT2 expression at the rat proximal tubule brush border membrane. J Physiol. 2003;553: 137-145.
47. Thorens B, Lodish HF, Brown D. Differential localization of two glucose transporter isoforms in rat kidney. Am J Physiol. 1990;259: C286-C294.
48. Chen J, Liu J, Zhang L, et al. Pentacyclic triterpenes. Part 3: synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase. Bioorg Med Chem Lett. 2006;16:2915-2919.
49. Henke BR, Sparks SM. Glycogen phosphorylase inhibitors. Mini- Rev Med Chem. 2006;6:845-857.
50. Wen X, Zhang P, Liu J, et al. Pentacyclic triterpenes. Part 2: synthesis and biological evaluation of maslinic acid derivatives as glycogen phosphorylase inhibitors. Bioorg Med Chem Lett. 2006; 16:722-726.